Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Major depressive disorder (MDD) often begins during adolescence and is projected to become the leading cause of global disease burden by the year 2030. Yet, approximately 40 % of depressed adolescents fail to respond to standard antidepressant treatment with a selective serotonin reuptake inhibitor (SSRI). Converging evidence suggests that depression is related to brain mitochondrial dysfunction. Our previous studies of MDD in adult and adolescent females suggest that augmentation of SSRI pharmacotherapy with creatine monohydrate (CM) may improve MDD outcomes. Neuroimaging with phosphorus-31 magnetic resonance spectroscopy ((31)P-MRS) can measure the high-energy phosphorus metabolites in vivo that reflect mitochondrial function. These include phosphocreatine (PCr), a substrate for the creatine kinase reaction that produces adenosine triphosphate. As part of the National Institute of Mental Health's experimental medicine initiative, we conducted a placebo-controlled dose-ranging study of adjunctive CM for adolescent females with SSRI-resistant MDD. Participants were randomized to receive placebo or CM 2, 4 or 10 g daily for 8 weeks. Pre- and post-treatment (31)P-MRS scans were used to measure frontal lobe PCr, to assess CM's target engagement with cerebral energy metabolism. Mean frontal lobe PCr increased by 4.6, 4.1 and 9.1 % in the 2, 4 and 10 g groups, respectively; in the placebo group, PCr fell by 0.7 %. There was no group difference in adverse events, weight gain or serum creatinine. Regression analysis of PCr and depression scores across the entire sample showed that frontal lobe PCr was inversely correlated with depression scores (p = 0.02). These results suggest that CM achieves target engagement with brain bioenergetics and that the target is correlated with a clinical signal. Further study of CM as a treatment for adolescent females with SSRI-resistant MDD is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“When combined with regular antidepressant use, 8-weeks of CrM supplementation reduced depressive symptoms in female adolescents and adults with major depression [86,87,88].”
From Creatine supplementation in women's health: a lifespan perspective (2021) · cites this paper as [87]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increase in cerebral PCr from 10 g of creatine supplementation was reported to be inversely related to symptoms of depression in adolescent females resistant to selective serotonin reuptake inhibitors [171]”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [171]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reports since the early 1980s have suggested that creatine metabolism and/or availability may have antidepressive effects [312,313,314,315,316,317,318].”
From Creatine in health and disease (2021) · cites this paper as [317]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Creatine monohydrate dosing protocols varied across studies. Weight-based regimens included approximately 0.1 g/kg/day, while fixed daily dosing ranged from 2 to 10 g/day. Several trials employed loading-maintenance strategies consisting of short loading phases (e.g., 20 g/day) followed by maintenance dosing (e.g., 5 g/day) [12-14].”
From Evaluating the Safety of Creatine Monohydrate in Adolescents: A Systematic Review of Renal, Hepatic, and Cardiometabolic Outcomes (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Across randomized controlled trials in pediatric and adolescent populations, no clinically meaningful changes were observed in serum creatinine, estimated glomerular filtration rate (eGFR), or other renal biomarkers [12-14].”
From Evaluating the Safety of Creatine Monohydrate in Adolescents: A Systematic Review of Renal, Hepatic, and Cardiometabolic Outcomes (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
White, H. (1980) · Econometrica · doi:10.2307/1912934 · Cited by 25,861
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Merikangas, K. R., He, J.-P., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., Benjet, C., Georgiades, K., & Swendsen, J. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.05.017 · Cited by 6,278
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
Psychiatric disorders in America: the epidemiologic catchment area study
(1991) · Choice Reviews Online · doi:10.5860/choice.28-5931 · Cited by 2,555
Hankin, B. L., Abramson, L. Y., Moffitt, T. E., Silva, P. A., McGee, R., & Angell, K. E. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.1.128 · Cited by 2,333
Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011
Seedat, S., Scott, K. M., Angermeyer, M. C., Berglund, P., Bromet, E. J., Brugha, T. S., Demyttenaere, K., de Girolamo, G., Haro, J. M., Jin, R., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.36 · Cited by 1,518
Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data
Cnaan, A., Laird, N. M., & Slasor, P. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19971030)16:20<2349::aid-sim667>3.0.co;2-e · Cited by 1,222
The increasing burden of depression
Briley, M., & Lépine (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s19617 · Cited by 1,211
Avenevoli, S., Swendsen, J., He, J.-P., Burstein, M., & Merikangas, K. R. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.10.010 · Cited by 1,202
Hyde, J. S., Mezulis, A. H., & Abramson, L. Y. (2008) · Psychological Review · doi:10.1037/0033-295x.115.2.291 · Cited by 1,146 · cited 2×
“Yet despite the evidence for gender-based differences in MDD pathophysiology (Hyde et al. 2008; Young and Korszun 2010) and treatment response (Yang et al.”
Major depressive disorder in older adolescents
Lewinsohn, P. M., Rohde, P., & Seeley, J. R. (1998) · Clinical Psychology Review · doi:10.1016/s0272-7358(98)00010-5 · Cited by 1,078 · cited 2×
“1991); in fact, MDD has a cumulative prevalence of 15–24 % by age 19 (Lewinsohn et al. 1998; Merikangas et al. 2010) and results in significant disability and mortality in this age group (Birmaher et al.”
Birmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056 · cited 1×
“(Birmaher et al. 1998).”
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Stress, sensitive periods and maturational events in adolescent depression
Andersen, S. L., & Teicher, M. H. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.01.004 · Cited by 1,005
Puberty and depression: the roles of age, pubertal status and pubertal timing.
ANGOLD, A., COSTELLO, E. J., & WORTHMAN, C. M. (1998) · Psychological Medicine · doi:10.1017/s003329179700593x · Cited by 989
Kuehner, C. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00204.x · Cited by 839
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Brent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., Vitiello, B., Ritz, L., Iyengar, S., Abebe, K., et al. (2008) · JAMA · doi:10.1001/jama.299.8.901 · Cited by 700
Mitochondrial creatine kinase in human health and disease
Schlattner, U., Tokarska-Schlattner, M., & Wallimann, T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.09.004 · Cited by 622
A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
Mrazek, D. A., Hornberger, J. C., Altar, C. A., & Degtiar, I. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300059 · Cited by 580
WADE, T. J., CAIRNEY, J., & PEVALIN, D. J. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202000-00013 · Cited by 527
Impaired mitochondrial function in psychiatric disorders
Manji, H., Kato, T., Di Prospero, N. A., Ness, S., Beal, M. F., Krams, M., & Chen, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3229 · Cited by 483
Keller, F., Grieb, J., Ernst, M., Spröber, N., Fegert, J. M., & Kölch, M. (2011) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000090 · Cited by 453
KOVACS, M. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199606000-00010 · Cited by 441 · cited 1×
“Keywords Creatine monohydrate · Phosphocreatine · Bioenergetics · Mitochondrial function · Adolescent depression · Women’s health · Phosphorus-31 magnetic resonance spectroscopy”
BackgroundFunctions and effects of creatine in the central nervous system
Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., & Widmer, H. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.035 · Cited by 368
Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
Depression in young people: Initial presentation and clinical course
McCAULEY, E., MYERS, K., MITCHELL, J., CALDERON, R., SCHLOREDT, K., & TREDER, R. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199307000-00003 · Cited by 343
Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333 · cited 3×
“The mitochondrial dysfunction associated with depression (Gardner and Boles 2011; Klinedinst and Regenold 2015) presents a tractable target for developing novel therapeutics and may also offer opportunities to improve the efficiency of drug development (Manji et al.”
Psychometric Properties of the Children's Depression Rating Scale–Revised in Adolescents
Mayes, T. L., Bernstein, I. H., Haley, C. L., Kennard, B. D., & Emslie, G. J. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0063 · Cited by 267
Burke, K. C. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330013002 · Cited by 263
Kantrowitz, J., Citrome, L., & Javitt, D. (2009) · CNS Drugs · doi:10.2165/00023210-200923080-00001 · Cited by 260
Statistics Notes: Correlation, regression, and repeated data
Bland, J. M., & Altman, D. G. (1994) · BMJ · doi:10.1136/bmj.308.6933.896 · Cited by 238
Sex, trauma, stress hormones and depression
Young, E., & Korszun, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.94 · Cited by 235 · cited 2×
“Yet despite the evidence for gender-based differences in MDD pathophysiology (Hyde et al. 2008; Young and Korszun 2010) and treatment response (Yang et al.”
Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study
Braissant, O., Henry, H., Loup, M., Eilers, B., & Bachmann, C. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00269-2 · Cited by 232
Increase of total creatine in human brain after oral supplementation of creatine-monohydrate
Dechent, P., Pouwels, P. J. W., Wilken, B., Hanefeld, F., & Frahm, J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r698 · Cited by 221
Pharmacological approaches to the challenge of treatment-resistant depression
Ionescu, D. F., Rosenbaum, J. F., & Alpert, J. E. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.2/dionescu · Cited by 212
Kato, T., Takahashi, S., Shioiri, T., & Inubushi, T. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90099-r · Cited by 205
Sex differences in mitochondrial (dys)function: Implications for neuroprotection
Demarest, T. G., & McCarthy, M. M. (2015) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9583-7 · Cited by 192 · cited 1×
“Finally, in consideration of the converging evidence for sex-based differences in brain mitochondrial functioning (Demarest and McCarthy 2015), there may also be opportunities to explore genderspecific pharmacotherapies in depression.”
Erondu, N., Gantz, I., Musser, B., Suryawanshi, S., Mallick, M., Addy, C., Cote, J., Bray, G., Fujioka, K., Bays, H., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.08.002 · Cited by 183
Tachikawa, M., Fukaya, M., Terasaki, T., Ohtsuki, S., & Watanabe, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03478.x · Cited by 173
National Institute of Mental Health Clinical Trials: New Opportunities, New Expectations
Insel, T. R., & Gogtay, N. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.426 · Cited by 170
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.116 · Cited by 168
Self-citationThe NIMH experimental medicine initiative
Insel, T. R. (2015) · World Psychiatry · doi:10.1002/wps.20227 · Cited by 165 · cited 6×
“In the context of the NIMH Experimental Medicine Initiative (Insel 2015), 31P-MRS is a translational tool capable of measuring ‘target engagement’ by quantifying the highenergy phosphorus-bearing neurometabolites involved in brain bioenergetics (Iosifescu and Renshaw 2003; Kato et al. 1992).”
InfluentialSex differences in the pharmacokinetics and pharmacodynamics of antidepressants: An updated review
Bigos, K. L., Pollock, B. G., Stankevich, B. A., & Bies, R. R. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.12.004 · Cited by 164
A mitochondrial bioenergetic basis of depression
Klinedinst, N. J., & Regenold, W. T. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9584-6 · Cited by 164
Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?
Allen, P. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.03.005 · Cited by 163
Correlation, regression, and repeated data: Authors' reply
Persaud, R. (1994) · BMJ · doi:10.1136/bmj.308.6942.1510a · Cited by 159
Efficacy of antidepressants in juvenile depression: meta-analysis
Tsapakis, E. M., Soldani, F., Tondo, L., & Baldessarini, R. J. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.031088 · Cited by 150
Lyoo, I. K., Kong, S. W., Sung, S. M., Hirashima, F., Parow, A., Hennen, J., Cohen, B. M., & Renshaw, P. F. (2003) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(03)00046-5 · Cited by 140
Self-citationBrain Bioenergetics and Response to Triiodothyronine Augmentation in Major Depressive Disorder
Iosifescu, D. V., Bolo, N. R., Nierenberg, A. A., Jensen, J. E., Fava, M., & Renshaw, P. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.020 · Cited by 139
Self-citationBebbington, P., Dunn, G., Jenkins, R., Lewis, G., Brugha, T., Farrell, M., & Meltzer, H. (2003) · International Review of Psychiatry · doi:10.1080/0954026021000045976 · Cited by 131
31 P magnetic resonance spectroscopy in the frontal lobe of major depressed patients
Volz, H.-P., Rzanny, R., Riehemann, S., May, S., Hegewald, H., Preussler, B., Hübner, G., Kaiser, W. A., & Sauer, H. (1998) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050052 · Cited by 125
Creatine as a booster for human brain function. How might it work?
Rae, C. D., & Bröer, S. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.08.010 · Cited by 123
Lyoo, I. K., Yoon, S., Kim, T.-S., Hwang, J., Kim, J. E., Won, W., Bae, S., & Renshaw, P. F. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010009 · Cited by 123
Self-citationRoy, A. (2006) · Biometrical Journal · doi:10.1002/bimj.200510192 · Cited by 123
Birmaher, B. B., Waterman, G. S., Ryan, N. D., Perel, J. M., McNabb, J., BALACH, L., Beaudry, M. B., NASR, F. N., KARAMBELKAR, J., ELTERICH, G., et al. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199805000-00015 · Cited by 121
Creatine monohydrate in resistant depression: A preliminary study
Roitman, S., Green, T., Osher, Y., Karni, N., & Levine, J. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00532.x · Cited by 118
Update on the Use of MR for Assessment and Diagnosis of Psychiatric Diseases
Agarwal, N., Port, J. D., Bazzocchi, M., & Renshaw, P. F. (2010) · Radiology · doi:10.1148/radiol.09090339 · Cited by 102
Self-citationMultinuclear Magnetic Resonance Spectroscopy Studies of Brain Purines in Major Depression
Renshaw, P. F., Parow, A. M., Hirashima, F., Ke, Y., Moore, C. M., Frederick, B. D., Fava, M., Hennen, J., & Cohen, B. M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2048 · Cited by 101
Self-citationAllen, P. J., D'Anci, K. E., Kanarek, R. B., & Renshaw, P. F. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.160 · Cited by 95
Self-citationExpression and Function of Agat, Gamt and CT1 in the Mammalian Brain
Braissant, O., Bachmann, C., & Henry, H. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_4 · Cited by 94
Kondo, D. G., Sung, Y.-H., Hellem, T. L., Fiedler, K. K., Shi, X., Jeong, E.-K., & Renshaw, P. F. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.010 · Cited by 86
Self-citationThe concentration of creatine in meat, offal and commercial dog food
Harris, R. C., Lowe, J. A., Warnes, K., & ORME, C. E. (1997) · Research in Veterinary Science · doi:10.1016/s0034-5288(97)90181-8 · Cited by 83
Evidence for the Management of Adolescent Depression
Lewandowski, R. E., Acri, M. C., Hoagwood, K. E., Olfson, M., Clarke, G., Gardner, W., Scholle, S. H., Byron, S., Kelleher, K., Pincus, H. A., et al. (2013) · Pediatrics · doi:10.1542/peds.2013-0600 · Cited by 81
Kinetics of creatine in blood and brain after intraperitoneal injection in the rat
Perasso, L., Cupello, A., Lunardi, G. L., Principato, M. C., Gandolfo, C., & Balestrino, M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02547-2 · Cited by 76
Treatment monitoring of brain creatine deficiency syndromes: a 1H- and 31P-MR spectroscopy study.
Bianchi, M. C., Tosetti, M., Battini, R., Leuzzi, V., Alessandri, M., Carducci, C., Antonozzi, I., & Cioni, G. (2007) · PubMed Central · Cited by 70
Cunha, M. P., Budni, J., Ludka, F. K., Pazini, F. L., Rosa, J. M., Oliveira‐Giacomelli, Á., Lopes, M. W., Tasca, C. I., Leal, R. B., & Rodrigues, A. L. S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9192-4 · Cited by 70
Cerebral energetic effects of creatine supplementation in humans
Pan, J. W., & Takahashi, K. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00717.2006 · Cited by 65 · cited 4×
“This study joins prior reports from our group (Lyoo et al. 2003; Hellem et al. 2015; Kondo et al. 2011b) and others (Pan and Takahashi 2007; Bianchi et al. 2007) in providing in vivo evidence that oral CM administration achieves target engagement with brain bioenergetics and the creatine kinase…”
InfluentialIosifescu, D. V., & Renshaw, P. F. (2003) · Harvard Review of Psychiatry · doi:10.1080/10673220303959 · Cited by 63
Self-citationAllen, P. J., D'Anci, K. E., Kanarek, R. B., & Renshaw, P. F. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.005 · Cited by 60
Self-citationSystematic review of management for treatment-resistant depression in adolescents
Zhou, X., Michael, K. D., Liu, Y., Del Giovane, C., Qin, B., Cohen, D., Gentile, S., & Xie, P. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0340-6 · Cited by 58
Kaymak, S. U., Demir, B., Oğuz, K. K., Şentürk, S., & Uluğ, B. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01951.x · Cited by 56
Lowe, M. T. J., Faull, R. L. M., Christie, D. L., & Waldvogel, H. J. (2015) · Journal of Comparative Neurology · doi:10.1002/cne.23667 · Cited by 54
Adžić, M., Lukić, I., Mitić, M., Djordjevic, J., Elaković, I., Djordjevic, A. D., Krstic–Demonacos, M., Matić, G. M., & Radojcic, M. B. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.07.019 · Cited by 52
Cunha, M. P., Pazini, F. L., Rosa, J. M., Ramos-Hryb, A. B., Oliveira‐Giacomelli, Á., Kaster, M. P., & Rodrigues, A. L. S. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9446-7 · Cited by 50
Cunha, M. P., Pazini, F. L., Ludka, F. K., Rosa, J. M., Oliveira‐Giacomelli, Á., Budni, J., Ramos-Hryb, A. B., Lieberknecht, V., Bettio, L. E. B., Martin‐de‐Saavedra, M. D., et al. (2015) · Amino Acids · doi:10.1007/s00726-014-1910-0 · Cited by 50
Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study
Hellem, T. L., Sung, Y.-H., Shi, X.-F., Pett, M. A., Latendresse, G., Morgan, J., Huber, R. S., Kuykendall, D., Lundberg, K. J., & Renshaw, P. F. (2015) · Journal of Dual Diagnosis · doi:10.1080/15504263.2015.1100471 · Cited by 49
Self-citationReview: Magnetic Resonance Spectroscopy Studies of Pediatric Major Depressive Disorder
Kondo, D. G., Hellem, T. L., Sung, Y.-H., Kim, N., Jeong, E.-K., DelMastro, K. K., Shi, X., & Renshaw, P. F. (2011) · Depression Research and Treatment · doi:10.1155/2011/650450 · Cited by 48
Self-citationYazigi Solis, M., de Salles Painelli, V., Giannini Artioli, G., Roschel, H., Concepción Otaduy, M., & Gualano, B. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513003802 · Cited by 46
Zhu, X.-H., Du, F., Zhang, N., Zhang, Y., Lei, H., Zhang, X., Qiao, H., Ugurbil, K., & Chen, W. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-543-5_15 · Cited by 39
Yang, S.-J., Kim, S.-Y., Stewart, R., Kim, J.-M., Shin, I.-S., Jung, S.-W., Lee, M.-S., Jeong, S.-H., & Jun, T.-Y. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.12.027 · Cited by 39
The Neural Effects of Psychotropic Medications in Children and Adolescents
Singh, M. K., & Chang, K. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.010 · Cited by 38
Atassi, N., Ratai, E.-M., Greenblatt, D. J., Pulley, D., Zhao, Y., Bombardier, J., Wallace, S., Eckenrode, J., Cudkowicz, M., & Dibernardo, A. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482961003797130 · Cited by 37
Efficacy of antidepressants in juvenile depression: meta-analysis
Tsapakis, E. M., Soldani, F., Tondo, L., & Baldessarini, R. (2008) · Annals of General Psychiatry · doi:10.1186/1744-859x-7-s1-s350 · Cited by 34
Nemets, B., & Levine, J. (2013) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32835ff20f · Cited by 31
Jeong, E., Sung, Y., Kim, S., Zuo, C. S., Shi, X., Mellon, E. A., & Renshaw, P. F. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1636 · Cited by 27
Self-citationCunha, M. P., Budni, J., Pazini, F. L., Oliveira‐Giacomelli, Á., Rosa, J. M., Lopes, M. W., Leal, R. B., & Rodrigues, A. L. S. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.03.004 · Cited by 26
Allen, P. J., DeBold, J. F., Rios, M., & Kanarek, R. B. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.12.014 · Cited by 25
Turner, C. E., Russell, B. R., & Gant, N. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.06.018 · Cited by 19
Ramírez, O., & Jiménez, E. (2002) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(02)00102-8 · Cited by 18
Optimizing early Go/No Go decisions in CNS drug development
Potter, W. Z. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.991715 · Cited by 13
Xu, C. J., Kanfer, J. N., Klunk, W. E., Xiong, Q. P., McClure, R. J., & Pettegrew, J. W. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815169 · Cited by 7
Ojugo (1999) · doi:10.1002/(sici)1099-1492(199912)12:8
Research works printed but not linked: 3
- First MB Williams JB Spitzer RL Gibbon M Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT) 2007 Biometrics Research, New York State Psychiatric Institute New York
- Huber PJ Lecam L Neyman J The behavior of maximum likelihood estimates under nonstandard conditions 1967 1 221 233 Proceedings of the fifth Berkeley symposium on mathematical statistics and probability. Volume 1: theory of statistics University of California Press Berkeley and Los Angeles, CA USA
- Poznanski EO Mokros HB Children’s Depression Rating Scale, Revised (CDRS-R) manual 1996 Western Psychological Services Los Angeles
Cited by
Antonio, J., Candow, D. G., Forbes, S. C., Gualano, B., Jagim, A. R., Kreider, R. B., Rawson, E. S., Smith-Ryan, A. E., VanDusseldorp, T. A., Willoughby, D. S., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00412-w · Cited by 345
“The increase in cerebral PCr from 10 g of creatine supplementation was reported to be inversely related to symptoms of depression in adolescent females resistant to selective serotonin reuptake inhibitors [171] It appears that creatine supplementation may be Antonio et al.”
BackgroundCreatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Dolan, E., Gualano, B., & Rawson, E. S. (2019) · European Journal of Sport Science · doi:10.1080/17461391.2018.1500644 · Cited by 171
Living High and Feeling Low: Altitude, Suicide, and Depression
Kious, B. M., Kondo, D. G., & Renshaw, P. F. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000158 · Cited by 143
Self-citationMagnetic Resonance Spectroscopy and its Clinical Applications: A Review
Faghihi, R., Zeinali-Rafsanjani, B., Mosleh‐Shirazi, M. A., Saeedi-Moghadam, M., Lotfi, M., Jalli, R., & Iravani, V. (2017) · Journal of medical imaging and radiation sciences · doi:10.1016/j.jmir.2017.06.004 · Cited by 106
Metadata
- Authors
- Kondo, D. G., Forrest, L. N., Shi, X., Sung, Y.-H., Hellem, T. L., Huber, R. S., & Renshaw, P. F.
- Affiliations
- University of Utah (US)
- Corresponding author
- Kondo, Douglas G.
- ORCID
- Venue
- Amino Acids
- Published
- 2016-02-23
- Volume
- 48
- Issue
- 8
- Pages
- 1941-1954
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- PMC
- PMC4974294
- OpenAlex
- W2284689049
- Cited by
- 79
- References
- 98
- Citations by year
- 2026: 16 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 6 · 2017: 5 · 2016: 4
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Amino Acids (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (5R21MH096858)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- creatine monohydrate, major depressive disorder, adolescent girls, phosphocreatine, brain bioenergetics, mitochondrial dysfunction, phosphorus-31 magnetic resonance spectroscopy, antidepressant augmentation, frontal lobe, target engagement, dose-ranging
- MeSH terms
- Adolescent, Adult, Brain, Creatinine, Major Depressive Disorder, Drug Resistance, Energy Metabolism, Female, Humans, Selective Serotonin Reuptake Inhibitors, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.